María Teresa Valenzuela

Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study

Marı́a Elena Santolaya, Miguel L. O’Ryan, María Teresa Valenzuela et al. · The Lancet · 2012 · 262 citations

Vaccination, Vaccine Safety, Healthy Adolescents +9

Clinical presentation of Bacillus Calmette-Guérin infections in patients with immunodeficiency syndromes.

B González, Santiago Moreno, R Burdach et al. · PubMed · 1989 · 98 citations

Bcg Infection, Bcg Vaccination, Immunodeficiencies +16

Persistence of antibodies in adolescents 18−24 months after immunization with one, two, or three doses of 4CMenB meningococcal serogroup B vaccine

Marı́a Elena Santolaya, Miguel O’Ryan, María Teresa Valenzuela et al. · Human Vaccines & Immunotherapeutics · 2013 · 82 citations · Full text

Two year review of intestinal intussusception in six large public hospitals of Santiago, Chile

Miguel O’Ryan, Yalda Lucero, Alfredo Peña et al. · The Pediatric Infectious Disease Journal · 2003 · 71 citations

Population-based surveillance for hospitalized and ambulatory pediatric invasive pneumococcal disease in Santiago, Chile

Rosanna Lagos, Alma Muñoz, María Teresa Valenzuela et al. · The Pediatric Infectious Disease Journal · 2002 · 66 citations